Source: Scientific Reports. Unidade: FM
Subjects: COVID-19, TRANSTORNOS RESPIRATÓRIOS, DISPNEIA, PACIENTES INTERNADOS
ABNT
JUNIOR, Carlos Toufen et al. Neuroleptics used in critical COVID associated with moderate-severe dyspnea after hospital discharge. Scientific Reports, v. 15, n. 1, 2025Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/84937. Acesso em: 26 jan. 2026.APA
Junior, C. T., Almeida, G. C. de, Pompeu, J. E., Carvalho, C. R. F. de, & Carvalho, C. R. R. D. (2025). Neuroleptics used in critical COVID associated with moderate-severe dyspnea after hospital discharge. Scientific Reports, 15( 1). doi:10.1038/s41598-025-91010-2NLM
Junior CT, Almeida GC de, Pompeu JE, Carvalho CRF de, Carvalho CRRD. Neuroleptics used in critical COVID associated with moderate-severe dyspnea after hospital discharge [Internet]. Scientific Reports. 2025 ; 15( 1):[citado 2026 jan. 26 ] Available from: https://observatorio.fm.usp.br/handle/OPI/84937Vancouver
Junior CT, Almeida GC de, Pompeu JE, Carvalho CRF de, Carvalho CRRD. Neuroleptics used in critical COVID associated with moderate-severe dyspnea after hospital discharge [Internet]. Scientific Reports. 2025 ; 15( 1):[citado 2026 jan. 26 ] Available from: https://observatorio.fm.usp.br/handle/OPI/84937


